Show simple item record

FieldValueLanguage
dc.contributor.authorBlanch, Bianca
dc.contributor.authorBuckley, Nicholas A.
dc.contributor.authorMellish, Leigh
dc.contributor.authorDawson, Andrew H.
dc.contributor.authorHaber, Paul S.
dc.contributor.authorPearson, Sallie-Anne
dc.date.accessioned2016-05-13
dc.date.available2016-05-13
dc.date.issued2015-05-13
dc.identifier.citationBlanch, B., Buckley, N., Mellish, L., Dawson, A., Haber, P., Pearson, S. (2015). Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013). Drug Safety, 38(6), 553-564, doi: 10.1007/s40264-015-0294-8.en
dc.identifier.urihttp://hdl.handle.net/2123/14919
dc.description.abstractBackground Prescription drug misuse is a growing public health concern globally. Routinely collected data provides a valuable tool for quantifying prescription drug misuse. Objective To synthesize the global literature investigating prescription drug misuse utilizing routinely collected, person-level prescription/dispensing data to examine reported measures, documented extent of misuse and associated factors. Methods We searched MEDLINE, Embase, CINAHL, MEDLINE In Process, Scopus citations and Google Scholar for relevant articles published between January 1 2000-July 31 2013. We screened 10,803 abstracts and retrieved 281 full-text manuscripts. Fifty-two peer-reviewed, English-language manuscripts met our inclusion criteria: an aim/method investigating prescription drug misuse and a measure of misuse derived exclusively from prescription/dispensing data. Results Four proxies of prescription drug misuse were used commonly across studies: number of prescribers, dispensing pharmacies, early refills and volume of drugs dispensed. We identified 89 unique measures of misuse across the 52 studies, reflecting the heterogeneity in how measures are constructed; single or composite; different thresholds, cohort definitions and time period of assessment. Consequently, it was not possible to make definitive comparisons about the extent (range reported: 0.01-93.5%), variations and factors associated with prescription drug misuse. Conclusion Routine data collections are relatively consistent across jurisdictions. Despite the heterogeneity of the current literature, our review identifies the capacity to develop universally accepted metrics of misuse applied to a core set of variables in prescription/dispensing claims. Our timely recommendations have the potential to unify the global research field and increase the capacity for routine surveillance of prescription drug misuse.en
dc.description.sponsorshipThis research has been supported, in part, by the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Medicines (APP1060407). Bianca Blanch is supported by a University of Sydney Postgraduate Award (2013–2016); Sallie-Anne Pearson is supported by a Cancer Institute New South Wales Career Development Fellowship (ID: 12/CDF/2-25); Nicholas Buckley and Andrew Dawson receive support for toxicovigilance studies through an NHMRC Program Grant (1055176); and Andrew Dawson is also supported by an NHRMC practitioner fellowship (1059542).en
dc.language.isoen_USen
dc.publisherSpringeren
dc.relationNHMRC 1060407 & NHMRC 1055176en
dc.rightsOtheren
dc.subjectUser Cohorten
dc.subjectCodeineen
dc.subjectComparison Cohorten
dc.subjectPrescription Drug Misuseen
dc.subjectOpioid Misuseen
dc.subjectEarly Refillen
dc.subjectPrescription Opioid Abuseen
dc.subjectTianeptineen
dc.subjectFlunitrazepamen
dc.subjectBenzodiazepineen
dc.subjectMisuseen
dc.subjectIndex Prescriptionen
dc.subjectBuprenorphineen
dc.subjectSystematic Reviewen
dc.subjectUser Groupen
dc.subjectOpiate Maintenanceen
dc.titleHarmonizing post-market surveillance of prescription drug misuse: A systematic review of observational studies using routinely collected data (2000–2013)en
dc.typeArticleen
dc.identifier.doi10.1007/s40264-015-0294-8
dc.type.pubtypeAuthor accepted manuscripten
dc.rights.otherThis is an Accepted Manuscript of an article published by Springer in Drug Safety Final publication is available at http://link.springer.com/article/10.1007%2Fs40264-015-0294-8en
usyd.facultyFaculty of Medicine and Health, School of Medical Sciencesen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.